Abstract:Background: Long-term exposure to acrylamide (AA) from diet sources may induce oxidative stress and chronic inflammation. However, the association between AA exposure and the prevalence of cardiovascular diseases (CVD) remains unclear. Objectives: We aimed to examine the association between blood exposure levels of AA biomarkers and the prevalence of main types of CVD in a general population of US adults. Methods: We analyzed the associations between AA hemoglobin biomarkers [ hemoglobin adducts of acrylamide (HbAA) and glycidamide (HbGA), sum of HbAA and HbGA (HbAA+HbGA), and ratio of HbGA to HbAA (HbGA: HbAA)] and self-reported diagnosis of CVD in 8290 adults (>= 20 years of age) from the National Health and Nutrition Examination Survey (NHANES) 2003-2006. Multivariable logistic regression models were employed for estimating the associations in three groups classified by the combination of smoking status and serum cotinine levels. Results: In people exposed to environmental tobacco smoke (n = 4670), HbGA, HbAA+HbGA, and HbGA: HbAA were significantly and inversely associated with the prevalence of total CVD (p < 0.0001, p = 0.0155, and p = 0.0014 for trend, respectively) after adjusting for various covariates. The odd ratios (ORs) for total CVD in the highest quartiles of HbGA, HbAA+ HbGA, and HbGA: HbAA were 0.311 [ 95% confidence interval (CI): 0.193-0.500], 0.664 (95% CI: 0.485-0.911), and 0.495 (95% CI: 0.326-0.752) when compared with the individual lowest quartiles. In active smokers (n = 2432), HbAA was positively associated with CVD risk (p = 0.0088 for trend), while HbGA: HbAA was inversely related to total CVD (p = 0.0137 for trend). However, no significant associations of any AA hemoglobin biomarker with total and individual CVD prevalence were observed in the nonsmoking group (n = 1188). Conclusions: AA hemoglobin biomarkers are significantly associated with CVD in the active smoking group and the group exposed to environmental tobacco smoke but not in the nonsmoking group. Further prospective studies should clarify the causal relationship between HbAA and HbGA and the prevalence of CVD.

Supplementary Table S28 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S32 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S26 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S15 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S14 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S17 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S9 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S13 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S18 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S40 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S36 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S30 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S42 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study.

Source Data for the Project Entitled "altered DNA Methylation Within DNMT3A, AHRR, LTA/TNF Loci Mediate the Effect of Smoking on Inflammatory Bowel Disease"

Exposure to Acrylamide and the Risk of Cardiovascular Diseases in the National Health and Nutrition Examination Survey 2003–2006

Supplementary Table S2 from The Effects of Black Raspberry as a Whole Food–Based Approach on Biomarkers of Oxidative Stress in Buccal Cells and Urine of Smokers

Association of urinary biomarkers of tobacco exposure with lung cancer risk in African American and White cigarette smokers in the Southern Community Cohort Study

Supplementary Figure S2 from the Effects of Black Raspberry As a Whole Food–Based Approach on Biomarkers of Oxidative Stress in Buccal Cells and Urine of Smokers

Association of Urinary N7-(1-hydroxyl-3-buten-1-yl) Guanine (EB-GII) Adducts and Butadiene-Mercapturic Acids with Lung Cancer Development in Cigarette Smokers

Supplementary Figure 1 from A Pooled Analysis of Smoking and Colorectal Cancer: Timing of Exposure and Interactions with Environmental Factors